Extensive clinical experience: Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 5, 2006, Pages 1637-1645

  Coco, Graziella ^a   Pra, Chiara Dal ^a   Presotto, Fabio ^a   Albergoni, Maria Paola ^b   Canova, Cristina ^a   Pedini, Beniamino ^a   Zanchetta, Renato ^a   Chen, Shu ^c   Furmaniak, Jadwiga ^c   Smith, Bernard Rees ^c   Mantero, Franco ^a   Betterle, Corrado ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c RSR LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; AUTOANTIBODY; CORTICOTROPIN; HLA DR ANTIGEN; HYDROCORTISONE; RENIN; CORTICOSTEROID; HLA DR1 ANTIGEN;

ADDISON DISEASE; ADOLESCENT; ADRENAL CORTEX; ADRENAL CORTEX FUNCTION; ADULT; AGED; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEREDITY; HUMAN; HYPOTHYROIDISM; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; ALGORITHM; BLOOD; DISEASE COURSE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RISK; STATISTICAL MODEL; SURVIVAL;

ADDISON DISEASE; ADOLESCENT; ADRENAL CORTEX; ADRENAL CORTEX HORMONES; ADULT; AGED; ALGORITHMS; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOLLOW-UP STUDIES; HLA-DR1 ANTIGEN; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; RISK; SURVIVAL ANALYSIS;

EID: 33646424095     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0860     Document Type: Article

References (32)

1. Cooper GS, Stroehla BC 2003 The epidemiology of autoimmune diseases. Autoimmun Rev 2:119-125
2. Arlt W, Allolio B 2003 Adrenal insufficiency. Lancet 361:1881-1893
3. Betterle C, Dal Pra C, Mantero F, Zanchetta R 2002 Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327-364
4. Tanaka H, Powell M, Chen S, Sanders JF, Sawicka J, Prentice L, Asawa T, Betterle C, Volpato M, Rees Smith B, Furmaniak J 1997 Autoimmune adrenal diseases - a new sensitive assay for measurement of steroid 21-hydroxylase autoantibodies. J Clin Endocrinol Metab 82:1440-1446
5. Scherbaum WA, Berg PA 1982 Development of adrenocortical failure in nonaddisonian patients with antibodies to adrenal cortex. Clin Endocrinol (Oxf) 16:345-352
6. Betterle C, Zanette F, Zanchetta R, Pedini B, Trevisan A, Mantero F, Rigon F 1983 Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease. Lancet 1:1238-1244
7. Ahonen P, Miettinen A, Perheentupa J 1987 Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 64:494-500
8. Betterle C, Scalici C, Presotto F, Pedini B, Moro L, Rigon F, Mantero F 1988 The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 117:467-475
9. De Bellis A, Bizzarro A, Rossi R, Amoresano Paglionico V, Crisciulo T, Lombardi G, Bellastella A 1993 Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies. J Clin Endocrinol Metab 76:1002-1007
10. Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Greggio NA, Sanzari M, Tedesco F, Pedini B, Boscaro M, Presotto F 1997 I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocrinol Metab 82:932-938
11. Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Zanchetta R, Greggio NA, Pedini B, Boscaro M, Presotto F 1997 II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab 82:939-942
12. Peterson P, Salmi H, Hyoty H, Miettinen A, Ilonen J, Reijonen H, Knip M, Akerblom HK, Krohn K 1997 Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Clin Immunol Immunopathol 82:37-42
13. Laureti S, De Bellis A, Muccitelli VI, Calcinaro F, Bizzarro A, Rossi R, Bellastella A, Santeusanio F, Falorni A 1998 Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab 83:3507-3511
14. Yu L, Brewer KW, Gates S, Wu A, Wang T, Babu SR, Gottlieb PA, Freed BM, Noble J, Erlich HA, Rewers MJ, Eisenbarth GS 1999 DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab 84:328-335
15. Wesche B, Jaeckel E, Trautwein C, Wedemeyer H, Falorni A, Frank H, von zur Muhlen A, Manns MP, Brabant G 2001 Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon α therapy for chronic hepatitis C. Gut 48:378-383
16. Barker JM, Ide A, Hostetler C, Yu L, Miao D, Fain PR, Eisenbarth GS, Gottlieb PA 2005 Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population. J Clin Endocrinol Metab 90:28-34
17. Stockigt JR, Collins RD, Biglieri EG 1971 Determination of plasma renin concentration by angiotensin I immunoassay: diagnostic import of a precise measurement of subnormal renin in hyperaldosteronism. Circ Res 20:175-187
18. Olerup O, Zetterguist H 1993 DR "low resolution" PCR-SSP typing - a correction and an update. Tissue Antigens 41:119-134
19. Aldener-Cannavà A., Olerup O 1994 HLA-DQB1 "low resolution" typing by PCR amplication with sequence-specific primers (PCR-SSP). Eur J Immunogenet 21:447-455
20. Cutler SJ, Ederer F 1958 Maximum utilization of the life table in analyzing survival. J Chronic Dis 8:699-712
21. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG 1977 Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39
22. Cox DR 1972 Regression model and life table analysis. J R Stat Soc B 34:187-220
23. Efron B, Gong G 1983 A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat 37:36-48
24. Altman D 1989 Bootstrap investigation of the stability of a Cox regression model. Stat Med 8:771-783
25. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 43:55-68
26. Diabetes Prevention Trial-Type 1 Diabetes Study Group 2002 Effect of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:1685-1691
27. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, Bottazzo GF 1990 Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1:147-149
28. Achenbach P, Warncke K, Reiter J, Naserke, Naserke HE, Williams AJ, Bingley PJ, Bonifacio E, Ziegler AG 2004 Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53:384-392
29. McGregor AM, Petersen MM, McLachlan SM, Rooke P, Rees Smith B, Hall R 1980 Carbimazole and the autoimmune response in Graves' disease. N Engl J Med 303:302-307
30. Cooper DS 2005 Antithyroid drugs. N Engl J Med 352:905-917
31. Fabris P, Floreani A, Tositti G, Vergani D, De Lalla F, Betterle C 2003 Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Aliment Pharmacol Ther 18:549-558
32. Prummel MF, Laurberg P 2003 Interferon-α and autoimmune thyroid disease. Thyroid 13:547-551